Table 5.
The number of MUs per segment, and the number of MUs for the longest and shortest segments, in the calculated plans for XiO, Prowess, and KonRad TPSs.
| Longest Segment (MU) | Shortest Segment(MU) | MU/Segment | |||||||
|---|---|---|---|---|---|---|---|---|---|
| KonRad | Prowess | XiO | KonRad | Prowess | XiO | KonRad | Prowess | XiO | Tumor Site |
| 14 | 33 | 11.3 | 5.2 | 1 | 3.7 | 6.45 | 8 | 5.3 | Low‐grade Glioma |
| 14.1 | 25 | 14.5 | 6.2 | 2 | 2.9 | 7 | 8.6 | 5.9 | Parotid Carcinoma |
| 17 | 21 | 16.4 | 5 | 1 | 4.8 | 7.9 | 5.8 | 6.9 | Pituitary Adenoma |
| 17 | 30 | 13.3 | 4 | 1 | 2.9 | 6.6 | 6.4 | 5 | Retinoblastoma |
| 16 | 16 | 12.8 | 5 | 1 | 1.1 | 6.1 | 5 | 4.7 | Parotid Carcinoma |
| 12.5 | 17 | 22.7 | 5.7 | 1 | 3.4 | 6.8 | 5.1 | 6.8 | High‐risk Medulloblastoma |
| 14 | 22 | 15 | 6.2 | 1 | 3.7 | 7.1 | 7.8 | 6.4 | Low‐risk Medulloblastoma |
| 23.9 | 19 | 43.3 | 4.3 | 2 | 2.6 | 8 | 7.4 | 7.6 | Nasolaboil RMS |
| 13.2 | 33 | 13.1 | 5 | 1 | 2 | 7.1 | 3.8 | 4.5 | Rhabdomyosarcoma (RMS) |
| 10 | 21 | 13.3 | 3 | 1 | 3.4 | 4.3 | 7 | 5.3 | Ependymoma |
| 20 | 16 | 27.8 | 5 | 1 | 2.1 | 6.8 | 4.2 | 4.9 | Maxillary Sarcoma |
| 15.6 | 23 | 18.5 | 4 | 1.2 | 3 | 6.7 | 6.3 | 5.8 | Mean |
| 3.8 | 6.4 | 9.6 | 1 | 0.4 | 1 | 1 | 1.6 | 1 | SD |